Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Webinar No. 1: Discovery Study Output

September 9, 2019

Webinar No. 1: Differentiating Pancreatic Ductal Adenocarcinoma (PDAC) from individuals with symptoms suggestive of PDAC, including type II diabetes, with ROC AUC values above 0.95

Presenters: Linda Mellby, PhD and Thomas King, MD, PhD, Immunovia

0:00 Introduction
1:14 IMMray™ Technology
7:30 IMMray PanCan-d for detection of stage I & II PDAC – JCO
9:42 IMMray™ PanCan-d optimization study results
15:32 Next steps
19:57 Summary
21:06 Q&A Session